Please login to the form below
CROs
This page shows the latest CROs news and features for those working in and with pharma, biotech and healthcare.
Researchers publish promising results for ultra-rare disease gene therapy method
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
Latest news
-
NICE recommends Ultomiris for NHS use in patients with rare blood disorders
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
-
Sarepta Therapeutics’ DMD gene therapy shows early success
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
-
BMS and bluebird bio gain FDA approval for multiple myeloma therapy
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
-
New data for Recordati’s Isturisa reinforces benefit in Cushing’s disease
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
-
bluebird bio reveals long-term data for Lenti-D gene therapy in CALD
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
More from news
Approximately 40 fully matching, plus 143 partially matching documents found.
Latest Intelligence
-
How early-stage clinical research is facilitating the new wave of personalised medicines
There are a number of adaptations that CROs and the wider healthcare industry must make to deliver on the promise of personalised medicines. ... This means that CROs need more sophisticated networks with volunteers, patient groups and the NHS in order to
-
Rare diseases: why they can be so difficult to identify
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
-
The lessons learned from COVID-19’s impact on oncology trials
Payments between drug sponsors, CROs and investigator sites are often a confusing process rife with delays.
-
A new era for UK-Japanese scientific research relations
Leading CROs have established dedicated Japanese patient recruitment and clinical teams in the capital to deliver these trials. ... UK CROs have a unique set of resources and expertise that support pharmaceutical companies in meeting the needs of the
-
Rare genetic diseases – what’s in store for 2021?
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.
Latest appointments
-
Dr Martine Dehlinger-Kremer becomes EUCROF president
Representing over 300 CROs across Europe, Dr Dehlinger-Kremer will be responsible for developing the foundation's educational activities and overseeing its plans for expansion.
-
XenoGesis appoints business development consultant
She has previously held director-level roles at US biotechs NovusLife and Cote Orphan, and US CROs Toxikon Corporation and XenoTech.
-
Cromsource expands executive leadership team
Dr McCall has nearly 25 years of experience in the pharmaceutical industry and has held senior leadership and advisory positions at CROs, private equity firms and non-profit organisations.
-
CROS NT names Mark Paul as senior VP of US operations
He joins from Veracity Logic. International contract research organisation CROS NT has appointed Mark Paul as senior vice president of its US operations. ... Andrew MacGarvey, CEO of CROS NT, added: “I am delighted to welcome Mark to our company.
-
PRC Clinical makes key management appointments
Commenting on Dowden's appointment, Taricco said: “Sue's proven track record working with sponsors and CROs gives PRC a unique advantage for customer satisfaction, quality assurance and successful trial management.”.
More from appointments
Approximately 10 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Innovative Trials named Best global Patient Recruitment Company of 2021
Founded in 2010, Innovative Trials is a UK-based company that works with some of the biggest pharmaceutical companies and Clinical Research Organisations (CROs) globally to help them reach their patient
-
Innovative Trials wins the Queen’s Award
and internationally, to help pharmaceutical companies and Clinical Research Organisations (CROs) bring new medicines to market. ... Founded in 2010, Innovative Trials works with some of the biggest pharmaceutical companies and CROs globally to help them
-
Innovative Trials
Innovative Trials has experience in 25 therapeutic areas and 90+ conditions working with some of the biggest global pharmaceuticals, Clinical Research Organisations (CROs) and biotech companies.
-
COUCH Health Engages Mark Duman as Chief Strategy Officer
COUCH Health works globally with pharma, biopharma, medical device companies and CROs, providing insights, patient recruitment, patient retention, and investigator site support. ... Through our work with pharma, biopharma, medical device companies and
-
COUCH Health Explores Lack of Ethnic Minorities in U.S. Clinical Trials
Through our work with pharma, biopharma, medical device companies and CROs, COUCH Health delivers a patient-first approach through patient insights, patient recruitment, patient retention, and investigator site support.
More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Bristol Myers Squibb announces positive trial results for treatment of MS
- FDA grants Pfizer/BioNTech’s COVID-19 vaccine emergency use authorisation for infants
- Virtual MSL/Sales training programs and events
- 6 trends shaping the future of personalized medicine
- Omnichannel strategies to revolutionize the healthcare professional experience
- The digital-first launch: the key to connected stakeholder experiences?
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Bristol Myers Squibb announces positive trial results for treatment of MS
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Roche shares new positive Ocrevus data for MS patients
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Annovis Bio’s lead therapeutic shows ‘significant improvements’ in Alzheimer’s, Parkinson’s
- Phase 3 trial initiated to evaluate AZ's Saphnelo in lupus nephritis
- New virtual health and care report from WHO and Novartis calls for ‘critical action’
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- Virtual MSL/Sales training programs and events
- Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
- Omnichannel strategies to revolutionize the healthcare professional experience
- Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...
